234
Views
29
CrossRef citations to date
0
Altmetric
Original Article

Fatty acid‐binding protein as marker for renal injury

, PhD
Pages 73-77 | Published online: 08 Jul 2009

References

  • Glatz J. F., van der Vusse G. J. Cellular fatty acid‐binding proteins: their function and physiological significance. Prog Lipid Res 1996; 35: 253–82
  • Kamijo A., Kimura K., Sugay T., et al. Urinary free fatty acids bound to albumin aggravate tubulointerstitial damage. Kidney Int 2002; 62: 1628–37
  • Thomas M. E., Harris K. P., Walls J., et al. Fatty acids exacerbate tubulointerstitial injury in protein‐overloaded proteinuria. Am J Physiol Renal Physiol 2002; 283: F640–7
  • Taylor S. A., Chivers I. D., Price R. G., et al. The assessment of biomarkers to detect nephrotoxicity using an integrated database. Environ Res 1997; 75: 23–33
  • Storch J., Thumser A. E. The fatty acid transport function of fatty acid‐binding proteins. Biochim Biophys Acta 2000; 1486: 28–44
  • Banaszak L., Winter N., Xu Z., Bernlohr D. A., Cowan S., Jones T. A. Lipid‐binding proteins: a family of fatty acid and retinoid transport proteins. Adv Protein Chem 1994; 45: 89–151
  • Van Nieuwenhoven F. A., Kleine A. H., Wodzig W. H., et al. Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid‐binding protein. Circulation 1995; 92: 2848–54
  • Maatman R. G., van Kuppevelt T., Veerkamp J. Two types of fatty acid‐binding protein in human kidney. Isolation, characterization and localization. Biochem J 1991; 273: 759–66
  • Pelsers M., Hanhoff T., van der Voort D., et al. Tissue specific types of fatty acid‐binding proteins, B‐ and H‐FABP, as novel markers for detection of brain injury. Clin Chem 2004; 50: 1568–75
  • Zschiesche W., Kleine A. H., Spitzer E., Veerkamp J. H., Glatz J. F. Histochemical localization of heart‐type fatty acid‐binding protein in human and murine tissues. Histochem Cell Biol 1995; 103: 147–56
  • Pelsers M. M., Morovat A., Alexander G. J., Hermens W. T., Trull A. K., Glatz J. F. Liver fatty acid‐binding protein as a sensitive serum marker of acute hepatocellular damage in liver transplant recipients. Clin Chem 2002; 48: 2055–7
  • Pelsers M. M., Namiot Z., Kisielewski W., et al. Intestinal‐type and liver‐type fatty acid‐binding protein in the intestine. Tissue distribution and clinical utility. Clin Biochem 2003; 36: 529–35
  • Pelsers M. M., Hermens W. T., Glatz J. F. C. Fatty acid‐binding proteins as plasma markers of tissue injury. Clin Chim Acta 2005; 352: 15–35
  • Gok M. A., Pelsers M. M., Glatz J. F., et al. Use of two biomarkers of renal ischemia to assess machine‐perfused non‐heart‐beating donor kidneys. Clin Chem 2003; 49: 172–5
  • Gok M. A., Pelsers M. M., Glatz J. F., et al. Comparison of perfusate activities of glutathione S‐transferase, alanine aminopeptidase and fatty acid‐binding protein in the assessment of non heart‐beating donor kidneys. Ann Clin Biochem 2003; 40: 252–8
  • Gok M. A., Pelsers M. M., Glatz J. F., et al. Do tissue damage markers used to assess machine perfused NHBD kidneys predict long‐term renal function post‐transplant?. Clin Chim Acta 2003; 338: 33–43
  • Robers M., van der Hulst F. F., Fischer M. A., et al. Development of a rapid microparticle‐enhanced turbidimetric immunoassay for plasma fatty acid‐binding protein, an early marker of acute myocardial infarction. Clin Chem 1998; 44: 1564–7
  • Kamijo A., Kimura K., Sugaya T., et al. Urinary fatty acid‐binding protein as new clinical marker for the progression of chronic renal disease. J Lab Clin Med 2004; 143: 23–30
  • Kamijo A., Sugaya T., Kimura K. Urinary fatty acid‐binding protein in renal disease. Clin Chim Acta 2006; 374: 1–7
  • Kamijo A., Sugaya T., Hikawa A., et al. Urinary excretion of fatty acid‐binding protein reflects stress overload on the proximal tubulus. Am J Pathol 2004; 165: 1243–55
  • Pelsers M. M., Chapelle J. P., Knapen M., et al. Influence of age and sex and day‐to‐day and within‐day biological variation on plasma concentrations of fatty acid‐binding protein and myoglobin in healthy subjects. Clin Chem 1999; 45: 441–3
  • Kamijo A., Sugaya T., Hikawa A., et al. Clinical evaluation of urinary excretion of liver‐type fatty acid‐binding protein as marker for monitoring chronic kidney disease: a multi‐center trail. J Clin Lab Med 2005; 145: 125–33
  • Kamijo‐Ikemori A., Sugaya T., Obama A., et al. Liver‐type fatty acid‐binding protein attenuates renal injury induced by unilateral ureteral obstruction. Am J Pathol 2006; 169: 1107–17
  • Nakamura T., Sugaya T., Node K., et al. Urinary excretion of liver‐type fatty acid‐binding protein in contrast medium‐induced nephropathy. Am J Kidney Dis 2006; 47: 439–44
  • Negishi K., Noiri E., Sugaya T., et al. A role of liver fatty acid‐binding protein in cisplatin‐induced renal injury. Kidney Int 2007; 72: 348–58
  • Yamamoto T., Noiri E., Ono Y., et al. Renal L‐type fatty acid‐binding protein in acute ischemic injury. J Am Soc Nephrol 2007; 18: 2894–902
  • Portilla D., Dent C., Sugaya T., et al. Liver fatty acid‐binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008, Epub ahead of print
  • Kamijo A., Sugaya T., Hikawa A., et al. Urinary liver‐type fatty acid‐binding protein as a useful biomarker in chronic kidney disease. Moll Cell Biochem 2006; 284: 175–82
  • Nakamura T., Sugaya T., Kawagoe Y., et al. Effect of pivastatin on urinary liver‐type fatty acid‐binding protein in patients with nondiabetic mild chronic kidney disease. Am J Nephrol 2006; 26: 82–6
  • De Zeeuw D., Remuzzi G., Parving H. H., et al. Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL. Kidney Int 2004; 65: 2309–20
  • Schnuelle P., Lorenz D., Trede M., et al. Impact of renal cadaveric transplantation on survival in end‐stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long‐term follow‐up. J Am Soc Nephrol 1998; 9: 2135–41
  • Kievit J. K., Pelsers M. M. A. L., Daemen M. A. R. C., Buurman W. A., Kootstra G., et al. Quantification of early ischemic renal injury in the rat using fatty acid‐binding protein [abstract]. Abstract Book of the European Meeting on Biomarkers of Organ Damage and Dysfunction. Cambridge UK 3–7 April 2000; 107
  • Roels H. A., Hoet P., Lison D. Usefulness of biomarkers of exposure to inorganic mercury, lead, or cadmium in controlling occupational and environmental risks of nephrotoxicity. Ren Fail 1999; 21: 251–62
  • Diamond G. L., Zlups R. K. Understanding renal toxicity of heavy metals. Toxicol Pathol 1998; 26: 92–103
  • Girardi G., Elias M. M. Verapamil protection against mercuric‐chloride induced renal glomular injury in rats. Toxicol Appl Pharmacol 1988; 152: 360–5
  • Berndt W. O. The role of transport in chemical nephrotoxicity. Toxicol Pathol 1998; 26: 52–7
  • Pelsers M. M. A. L., Davies D. Fatty acid‐binding protein: a new biomarker of nephrotoxicity in the rat [abstract]. Abstract Book to the 4th international conference on lipid binding proteins. Maastricht the Netherlands 2001

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.